Germany, April 9 -- Germany based Ecol Studio SpA has secured contract from Universitatsklinikum Munster for Engineering studies - IIT study CLEAR "Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)". The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....